CDKN2A and melanoma: With respect to the host risk factor, it is known that about 10% of people with melanoma have a family history of the disease, and hereditary mutations are found in the NRAS gene, but they are mostly in the cyclin dependent kinase inhibitor 2A (CDKN2A) gene, which is involved in cell cycle regulation and progression as well as in senescence [2,25].